Related Experiment Video

Updated: Jun 2, 2026

Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

What is the power of evidence recommending routine probiotics for necrotizing enterocolitis prevention in preterm

Walter A Mihatsch1

  • 1Department of Pediatrics, Diakonieklinikum, Schwäbisch Hall, Germany. walter.mihatsch@diaksha.de

Current Opinion in Clinical Nutrition and Metabolic Care
|April 20, 2011
PubMed

Insights

Certain probiotics show promise in reducing severe necrotizing enterocolitis (NEC) in preterm infants, but routine use for all infants is not yet supported by strong evidence. Further research on specific probiotic strains is needed.

Area of Science:

  • Neonatal research
  • Gastroenterology
  • Evidence-based medicine

Background:

  • Necrotizing enterocolitis (NEC) and mortality are significant concerns for preterm infants.
  • The routine use of probiotics to prevent these outcomes is debated in scientific literature.

Purpose of the Study:

  • To analyze the evidence level of randomized controlled trials (RCTs) on probiotics for reducing severe NEC and mortality in preterm infants.
  • To evaluate the efficacy of different probiotic products based on the Oxford Center for Evidence-based Medicine approach.

Main Methods:

  • Systematic review and analysis of published randomized controlled trials (RCTs).
  • Evaluation of evidence using the Oxford Center for Evidence-based Medicine criteria.
  • Assessment of data from 16 RCTs involving 12 different probiotic preparations in preterm infants.

Main Results:

  • Probiotic interventions are not uniform; meta-analyses may be misleading.
  • Certain probiotics demonstrate potential benefits for severe NEC (Level of Evidence 2b).
  • Data exists on outcomes including NEC, mortality, sepsis, and feeding advancement.

Conclusions:

  • Encouraging data supports probiotic use in high-incidence NEC settings (LoE 2b).
  • No Level 1a evidence currently supports routine probiotic administration for all preterm infants.
  • Further well-designed RCTs focusing on specific probiotics are necessary.
Abstract

More Related Videos

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation09:02

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...